Search results for: platform trial regulatory sponsor

Expected enrollment for this trial is expected to begin in June 2023. The Department of Defense (DOD) is funding and has established this posttraumatic stress disorder (PTSD) adaptive platform trial (APT). The team is now seeking interested partners to serve as the regulatory sponsor and holder of the existing Master Protocol Investigational New Drug (IND) application to the U.S.

This announcement serves as a Sources Sought Notice issued for the purpose of market research in accordance with Federal Acquisition Regulation (FAR) Part 10 for a possible requirement for Tyndall Air Force Base, Florida. This sources sought is issued solely for information and planning purposes and does not constitute a solicitation or a commitment or obligation on the part of the Government to issue a solicitation. DO NOT submit a quote or proposal in response to this notice. Any information provided by industry to the Government as a result of this notice is voluntary. The Government will not pay for any information submitted in response to this notice. This Sources Sought is posted to inquire for anyone with the ability to provide the p...